Literature DB >> 156038

Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.

P Whur, J J Silcox, J A Boston, D C Williams.   

Abstract

Plasminogen activator of cell origin converts the plasma protein plasminogen to the proteolytic enzyme plasmin. Recently, high levels of activator have been observed to be particularly associated with tumours and transformed cells, and a functional relationship between plasminogen activation and malignancy has been proposed. In this paper we have attempted to induce transformation-like morphology and growth in a population of confluent quiescent cells in tissue culture, by inducing plasminogen activation. Untransformed 3T3 cells grown to confluence in plasminogen-free medium were subjected to plasminogen activation by the addition of urokinase and plasminogen or plasminogen-containing acid-treated serum, or plasmin. Under these conditions, the previously well ordered monolayers became disrupted, with multilayering, and discontinuities in the cell sheet, and the cells simultaneously grew to significantly higher densities. Removal of the plasmin-containing medium supplements effected some restoration of normal morphology. Thus, lhen plasmin was present 3T3 cells did not become transformed, but expresses transformation-like features. Well ordered monolayer morphology and quiescence in 3T3 cells at confluence are therefore dependent upon the absence of plasminogen activation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156038      PMCID: PMC2009998          DOI: 10.1038/bjc.1979.126

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  45 in total

1.  TRANSFORMATION OF PROPERTIES OF AN ESTABLISHED CELL LINE BY SV40 AND POLYOMA VIRUS.

Authors:  G J TODARO; H GREEN; B D GOLDBERG
Journal:  Proc Natl Acad Sci U S A       Date:  1964-01       Impact factor: 11.205

2.  PARTIAL PURIFICATION AND PROPERTIES OF THE PLASMINOGEN ACTIVATOR FROM PIG HEART.

Authors:  F BACHMANN; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  Biochemistry       Date:  1964-10       Impact factor: 3.162

3.  The histological localisation of fibrinolysin activator.

Authors:  A S TODD
Journal:  J Pathol Bacteriol       Date:  1959-07

4.  Heat denaturation of plasminogen in the fibrin plate method.

Authors:  M LASSEN
Journal:  Acta Physiol Scand       Date:  1953-02-28

5.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Tumour promotor induces plasminogen activator.

Authors:  M Wigler; I B Weinstein
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

7.  In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells.

Authors:  P A Jones; W E Laug; A Gardner; C A Nye; L M Fink; W F Benedict
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

8.  The relationship between tumorigenicity, growth in agar and fibrinolytic activity in a line of human osteosarcoma cells.

Authors:  P A Jones; J S Rhim; H Isaacs; R M McAllister
Journal:  Int J Cancer       Date:  1975-10-15       Impact factor: 7.396

9.  Relationship between fibrinolysis of cultured cells and malignancy.

Authors:  W E Laug; P A Jones; W F Benedict
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

10.  Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation.

Authors:  P A Jones; W E Laug; W F Benedict
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

View more
  2 in total

1.  Potential proteolytic activity of human plasma fibronectin.

Authors:  V Keil-Dlouha; T Planchenault
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Plasminogen activator in cultured Lewis lung carcinoma cells measured by chromogenic substrate assay.

Authors:  P Whur; M Magudia; J Boston; J Lockwood; D C Williams
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.